ES8600932A1 - Procedimiento para la obtencion de antiflogisticos de doposito. - Google Patents

Procedimiento para la obtencion de antiflogisticos de doposito.

Info

Publication number
ES8600932A1
ES8600932A1 ES533848A ES533848A ES8600932A1 ES 8600932 A1 ES8600932 A1 ES 8600932A1 ES 533848 A ES533848 A ES 533848A ES 533848 A ES533848 A ES 533848A ES 8600932 A1 ES8600932 A1 ES 8600932A1
Authority
ES
Spain
Prior art keywords
depot
antiphlogistics
alcohols
glycerides
amides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES533848A
Other languages
English (en)
Other versions
ES533848A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Troponwerke GmbH
Original Assignee
Troponwerke GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Troponwerke GmbH filed Critical Troponwerke GmbH
Publication of ES8600932A1 publication Critical patent/ES8600932A1/es
Publication of ES533848A0 publication Critical patent/ES533848A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/195Carboxylic acids, e.g. valproic acid having an amino group
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyridine Compounds (AREA)
  • Optical Fibers, Optical Fiber Cores, And Optical Fiber Bundles (AREA)
  • Inorganic Insulating Materials (AREA)
  • Organic Insulating Materials (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)
  • Dental Preparations (AREA)
  • Reinforced Plastic Materials (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

PROCEDIMIENTO PARA LA OBTENCION DE ANTIFLOGISTICOS DE DEPOSITO. COMPRENDE: HACER REACCIONAR UNA SAL METALICA DEL ACIDO N-(3-TRIFLUORMETILFENIL)-ANTRANILICO CON UN COMPUESTO DE FORMULA X-CH2-CH2-O-R EN DONDE R ES HIDROXIETILO Y X ES HALOGENO O UN RESTO DEL ACIDO SULFONICO; MEZCLAR INTENSAMENTE CON UN AGENTE DE SUSPENSION DEL GRUPO: VISCOLEO MIRISTATO DE ISOPROPILO OLEATO DE ETILO U OTROS; Y ENVASAR DE TAL MODO QUE EN EL AGENTE TERMINADO ESTE CONTENIDO DE UN 3 A UN 80% EN PESO DEL COMPUESTO Y DE UN 10% A UN 70% EN PESO DEL AGENTE DE SUSPENSION. SE UTILIZAN COMO ANTIFLOGISTICOS/ANALGESICOS.
ES533848A 1983-07-05 1984-06-29 Procedimiento para la obtencion de antiflogisticos de doposito. Granted ES533848A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833324192 DE3324192A1 (de) 1983-07-05 1983-07-05 Depot-antiphlogistika

Publications (2)

Publication Number Publication Date
ES8600932A1 true ES8600932A1 (es) 1985-10-16
ES533848A0 ES533848A0 (es) 1985-10-16

Family

ID=6203192

Family Applications (4)

Application Number Title Priority Date Filing Date
ES533848A Granted ES533848A0 (es) 1983-07-05 1984-06-29 Procedimiento para la obtencion de antiflogisticos de doposito.
ES542316A Granted ES542316A0 (es) 1983-07-05 1985-04-16 Procedimiento para la obtencion de antiflogisticos de depo- sito
ES542318A Expired ES8603267A1 (es) 1983-07-05 1985-04-16 Procedimiento para la obtencion de antiflogisticos de depo- sito
ES542317A Expired ES8605984A1 (es) 1983-07-05 1985-04-16 Procedimiento para la obtencion de antiflogisticos de depo- sito

Family Applications After (3)

Application Number Title Priority Date Filing Date
ES542316A Granted ES542316A0 (es) 1983-07-05 1985-04-16 Procedimiento para la obtencion de antiflogisticos de depo- sito
ES542318A Expired ES8603267A1 (es) 1983-07-05 1985-04-16 Procedimiento para la obtencion de antiflogisticos de depo- sito
ES542317A Expired ES8605984A1 (es) 1983-07-05 1985-04-16 Procedimiento para la obtencion de antiflogisticos de depo- sito

Country Status (10)

Country Link
US (1) US4594357A (es)
EP (1) EP0130524B1 (es)
JP (1) JPH0647534B2 (es)
KR (1) KR910010019B1 (es)
AT (1) ATE45673T1 (es)
DE (2) DE3324192A1 (es)
DK (1) DK165441C (es)
ES (4) ES533848A0 (es)
GR (1) GR82116B (es)
PT (1) PT78837B (es)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3446873A1 (de) * 1984-12-21 1986-07-10 Merckle Gmbh Fluessige diclofenac-zubereitungen
DE3726797A1 (de) * 1987-08-12 1989-02-23 Bayer Ag Arzneimittel fuer den bereich der mundhoehle
US5360593A (en) * 1987-12-29 1994-11-01 Alcon Laboratories, Inc. Heat sterilization of labile antibiotics
DE3902079A1 (de) * 1988-04-15 1989-10-26 Bayer Ag I.m. injektionsformen von gyrase-inhibitoren
HU205249B (en) * 1990-11-09 1992-04-28 Egyt Gyogyszervegyeszeti Gyar Process for producing suspensive aerosole composition
JP2002512597A (ja) * 1996-12-20 2002-04-23 アルザ コーポレイション 注射可能な貯留槽ゲル組成物およびこの組成物の製造方法
CA2304568C (en) * 1997-09-30 2008-08-12 Eli Lilly And Company Olanzapine pamoate formulations
AU2002322720B2 (en) 2001-07-25 2008-11-13 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
EP1838716B1 (en) * 2005-01-05 2011-06-01 Eli Lilly And Company Olanzapine pamoate dihydrate
CN102379684B (zh) 2005-04-28 2014-11-19 普罗透斯数字保健公司 药物信息系统
KR20090071598A (ko) 2006-09-18 2009-07-01 랩터 파마슈티컬 인코포레이티드 수용체 결합 단백질(rap)-접합체 투여에 의한 간 질환의 치료
EP2398500B1 (en) 2009-02-20 2019-03-13 2-BBB Medicines B.V. Glutathione-based drug delivery system
ES2942923T3 (es) 2009-05-06 2023-06-07 Laboratory Skin Care Inc Composiciones de administración dérmica que comprenden complejos de agente activo-partículas de fosfato de calcio y métodos de uso de las mismas
US20120077778A1 (en) 2010-09-29 2012-03-29 Andrea Bourdelais Ladder-Frame Polyether Conjugates

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3590039A (en) * 1967-12-20 1971-06-29 Geigy Chem Corp N - (alpha,alpha,alpha,alpha',alpha',alpha' -hexafluoro - 3,5 - xylyl) anthranilic acid and salts thereof
US3673243A (en) * 1968-05-08 1972-06-27 Sumitomo Chemical Co Novel process for producing o-anilinophenylaliphatic acid derivatives
US3678094A (en) * 1970-04-20 1972-07-18 Merck & Co Inc Substituted anilino carboxylic acids
JPS474775U (es) * 1971-02-04 1972-09-12
US3778470A (en) * 1972-08-23 1973-12-11 A Sallman Chemical intermediates for the production of substituted 2-anilinophenylacetic acids and esters
JPS5314606A (en) * 1976-07-27 1978-02-09 Kawasaki Steel Co Good hydrogen brittleness resistance line pipe steel
JPS5337857A (en) * 1976-09-20 1978-04-07 Matsushita Electric Industrial Co Ltd Composite hybrid integrated circuit
US4307113A (en) * 1978-04-20 1981-12-22 Sandoz, Inc. Anthranilic acid derivatives
JPS5562049A (en) * 1978-10-31 1980-05-10 Bago Sa Labor Novel ester of phenyll and pyridinee33carboxylic acid and its manufacture
US4325949A (en) * 1980-02-15 1982-04-20 American Cyanamid Company Combinations of agents which give enhanced anti-inflammatory activity
DE3026402A1 (de) * 1980-07-11 1982-02-04 Syntex Corp., Palo Alto, Calif. Die verwendung analgetischer und nicht-hormonaler, entzuendungshemmender mittel bei der behandlung von mikrovaskulaeren erkrankungen
JPS5859912A (ja) * 1981-10-06 1983-04-09 Green Cross Corp:The 鎮痛消炎物質脂肪乳剤

Also Published As

Publication number Publication date
ES542318A0 (es) 1985-12-16
DK328684D0 (da) 1984-07-04
US4594357A (en) 1986-06-10
DK165441B (da) 1992-11-30
KR850000977A (ko) 1985-03-14
PT78837A (en) 1984-08-01
JPH0647534B2 (ja) 1994-06-22
DE3324192A1 (de) 1985-01-17
JPS6036408A (ja) 1985-02-25
ES8603267A1 (es) 1985-12-16
PT78837B (en) 1986-06-02
ATE45673T1 (de) 1989-09-15
DE3479478D1 (en) 1989-09-28
ES542317A0 (es) 1986-04-16
ES8605984A1 (es) 1986-04-16
ES8603266A1 (es) 1985-12-16
EP0130524A3 (en) 1986-08-13
DK165441C (da) 1993-04-19
ES542316A0 (es) 1985-12-16
GR82116B (es) 1984-12-13
KR910010019B1 (ko) 1991-12-10
ES533848A0 (es) 1985-10-16
EP0130524A2 (de) 1985-01-09
DK328684A (da) 1985-01-06
EP0130524B1 (de) 1989-08-23

Similar Documents

Publication Publication Date Title
ES8605984A1 (es) Procedimiento para la obtencion de antiflogisticos de depo- sito
ZA938936B (en) New taxoid-based compositions
GB1534823A (en) Dental chairs or like patient supporting devices
GR860586B (en) Phenyl- carbamates
IT1127221B (it) Composizione a base di magnesio per l'immagazzinamento di idrogeno e procedimento per la preparazione di tale composizione
ES8403472A1 (es) Procedimiento para la obtencion de un medio para combatir las pestes a base de como minimo de aminocetal.
MY100883A (en) The use of salicylic acid esters as perfumes, perfume compositions containing them and new salicylic esters.
ES8101530A1 (es) Un procedimiento para la preparacion de alcoholes beta-gama-dihidro-poliprenilicos.
ZA9410023B (en) Herbicides
ATE175344T1 (de) Gelbildende präparate, die optisch angereicherte gelbildner enthalten
GB1487796A (en) Perfuming agents containing sesquiterpenic derivatives
HUT33961A (en) Pesticide compositions containing ester of tricyclohexyl-tinhidroxide and process for producing the active agents
CA1274851C (en) 4-ALKYLPHENYL-2-ALKOXYETHYL ETHERS AND AROMATIC COMPOSITIONS CONTAINING THEM
EP0034721A3 (en) Polypeptide and its production and use
HU171992B (hu) Insekticidnye, akaricidnye i nematocidnye kompozicija soderzhahhie slozhnye efiry i efiramidy 0-triazolil-skobka-tiono-skobka zakryta-fosfornojj-, skobka-fosfonnojj-ili fosfinnojj-skobka zakryta-kislot, i sposob poluchenija aktivnykh agentov
HUT37136A (en) Herbicide compositions containing substituted oxiranes as active agents and process for producing the substituted oxiranes
SU952037A1 (ru) Комплект усиливающих рентгеновских экранов
AU8424682A (en) Varification of recorded messages
ES8503321A1 (es) Procedimiento para desengrasar metales y para limpiar en seco materiales textiles en presencia simultanea de agua.
UA13708A1 (uk) Кріопротектор
UA16859A1 (uk) Кріопротектор гемопоетичhих клітиh
JPS53112834A (en) Hydroxybenzoic ester and antiseptic agent containing the same as effective ingredient
AU91355S (en) Holder for video tape cassettes
SU1203863A1 (ru) 6-циклогексил-2-окса-6-азаспиро (3,3) гептан, подавляющий рост сульфатвосстанавливающих бактерий
PH16863A (en) New 3h-naphtho(1,3-d)imidazoles,compositions containing the compounds and use of the compounds